Oseltamivir treatment during influenza episodes is associated with a reduced risk for serious neuropsychiatric events among children and teens.

The FDA has removed the recommended pause in the use of Valneva’s chikungunya vaccine Ixchiq in individuals aged 60 years and older.

The presence of excess weight or obesity in long COVID is significantly associated with neurological and neuropsychiatric symptom development.

Vaccination with the updated COVID-19 mRNA vaccine containing the SARS-CoV-2 Omicron JN.1 lineage was not associated with an increased risk for 29 adverse events.

HealthDay News — Treatment of multisystem inflammatory syndrome in children (MISC), a postacute sequela of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), with larazotide speeds ...